Shares of revenue are estimates for year ended December 31, 2025, not figures from a filing.
Thermo Scientific Orbitrap Tribrid Apex Mass Spectrometer
An instrument that measures molecules in samples to help researchers study complex biology, medicines, and other substances.
Thermo Scientific Vanquish Amplify ultra-high-performance liquid chromatography system
An instrument that separates and analyzes substances in liquid samples, including sensitive biological molecules.
Applied Biosystems PowerFlex Thermal Cycler
A laboratory instrument that repeatedly heats and cools samples to copy selected genetic material for testing or research.
DynaDrive single-use bioreactors
Containers and equipment used to grow cells and produce medicines; the single-use parts are replaced between production runs.
Diagnostic test kits and reagents
Tests and the chemicals needed to detect or monitor conditions such as allergies, thyroid disorders, infections, and drug levels.
PPD and Patheon services
PPD provides clinical research and clinical-trial services; Patheon develops and manufactures medicines for pharmaceutical and biotechnology customers.
Three ratings, each a percentile against the 43 companies we cover in Diagnostics and Research. Deliberately kept apart rather than blended into one score — cheap, rising and well-run are three different facts, and a single number would hide which one is which.
Middle of its industry
The most recent month is left out on purpose: returns tend to persist over 7–12 months and the newest one tends to reverse. This describes what the price has done, and says nothing about what it will do.
Above most of its industry
Yields, so higher means cheaper — a loss-making company ranks last instead of dropping out. Cheap is not the same as good: a high yield is often a price that fell for a reason. All five measures available.
1 check not reported
What management does with the money — scored on whatever the filings answer, never as a share of the total.
A description of where this company sits among its competitors, not a recommendation. Ratings updated Sep 26, 2026.
Thermo Fisher sells products and services to pharmaceutical and biotechnology companies, hospitals, clinical laboratories, universities, government agencies, and industrial customers. Its products include research supplies, instruments for analyzing samples, and diagnostic tests; its services include clinical-trial work and manufacturing medicines for customers. In the second quarter of 2026, management said customer demand had strengthened across its major markets.
Built from Thermo Fisher Scientific Inc.’s own filings with the SEC. Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
TMO · NYSE · Healthcare · Diagnostics and Research
Next earnings: October 28, 2026
$675.00-0.5%Sep 25 close
Thermo Fisher sells laboratory supplies, scientific instruments, diagnostic tests, and services for developing and making medicines.
Is the business getting bigger, and does it generate real cash?
Showing 2 of 41 quarters of Thermo Fisher Scientific Inc.’s grade history. The other 39 go back to September 2016.